Joan A. Barbera

Aug 29, 2024 | erj.ersjournals.com | Joan A. Barbera |Vincent Cottin |Sergio Harari |Joanna Pepke-Zaba

IntroductionIt has long been known that chronic lung disease (CLD) is frequently complicated by pulmonary hypertension (PH) and right ventricular (RV) dysfunction. Despite this clear association, the prevalence, clinical significance and treatment options for PH in CLD are still under investigation. The heterogeneity of PH in CLD increases the difficulty in characterising this group. In addition, the definitions of PH in general have evolved.